- Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma
[作者：Maur, M; Tomasello, C; Frassoldati, A; Dieci, MV; Barbieri, E; Conte, P,期刊：Journal of clinical oncology, 页码：E76-E78 , 文章类型： Article，,卷期：2012年30-6]
-
- Unilateral Exophthalmos and Multiple Subcutaneous Nodules As a Result of Extranodal Marginal Zone Lymphoma
[作者：Vincenti, D; Orofino, N; Ferrario, A; Goldaniga, M; Rossi, F; Olivero, B; Baldini, L,期刊：Journal of clinical oncology, 页码：E69-E73 , 文章类型： Article，,卷期：2012年30-6]
-
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
[作者：Amir, E; Miller, N; Geddie, W; Freedman, O; Kassam, F; Simmons, C; Oldfield, M; Dranitsaris, G; Tomlinson, G; Laupacis, A; Tannock, IF; Clemons, M,期刊：Journal of clinical oncology, 页码：587-592 , 文章类型： Article，,卷期：2012年30-6]
- Purpose Decisions about treatment for women with metastatic breast cancer are usually based on the estrogen (ER), progesterone (PgR), and human epidermal growth factor receptor 2 (HER2) status of the primary tumor. Retro...
- Zirconium-89-Trastuzumab Positron Emission Tomography As a Tool to Solve a Clinical Dilemma in a Patient With Breast Cancer
[作者：Gaykema, SBM; Brouwers, AH; Hovenga, S; Lub-de Hooge, MN; de Vries, EGE; Schroder, CP,期刊：Journal of clinical oncology, 页码：E74-E75 , 文章类型： Article，,卷期：2012年30-6]
-
- Randomized Phase III Study of Thoracic Radiation in Combination With Paclitaxel and Carboplatin With or Without Thalidomide in Patients With Stage III Non-Small-Cell Lung Cancer: The ECOG 3598 Study
[作者：Hoang, T; Dahlberg, SE; Schiller, JH; Mehta, MP; Fitzgerald, TJ; Belinsky, SA; Johnson, DH,期刊：Journal of clinical oncology, 页码：616-622 , 文章类型： Article，,卷期：2012年30-6]
- Purpose The primary objective of this study was to compare the survival of patients with unresectable stage III non-small-cell lung cancer (NSCLC) treated with combined chemoradiotherapy with or without thalidomide. Pati...
- Recommendations for Clinical Trials of Off-Label Drugs Used to Treat Advanced-Stage Cancer
[作者：Mullins, CD; Montgomery, R; Abernethy, AP; Hussain, A; Pearson, SD; Tunis, S,期刊：Journal of clinical oncology, 页码：661-666 , 文章类型： Article，,卷期：2012年30-6]
- Purpose To provide recommendations to trialists and sponsors that guide the design and implementation of prospective postapproval clinical trials for oncology drugs used outside US Food and Drug Administration-labeled in...
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
[作者：Coiffier, B; Pro, B; Prince, HM; Foss, F; Sokol, L; Greenwood, M; Caballero, D; Borchmann, P; Morschhauser, F; Wilhelm, M; Pinter-Brown, L; Padmanabhan, S; Shustov, A; Nichols, J; Carroll, S; Balser, J; Balser, B; Horwitz, S,期刊：Journal of clinical oncology, 页码：631-636 , 文章类型： Article，,卷期：2012年30-6]
- Purpose Romidepsin is a structurally unique, potent class 1 selective histone deacetylase inhibitor. The primary objective of this international, pivotal, single-arm, phase II trial was to confirm the efficacy of romidep...
- Cancer Genomics: Technology, Discovery, and Translation
[作者：Tran, B; Dancey, JE; Kamel-Reid, S; McPherson, JD; Bedard, PL; Brown, AMK; Zhang, T; Shaw, P; Onetto, N; Stein, L; Hudson, TJ; Neel, BG; Siu, LL,期刊：Journal of clinical oncology, 页码：647-660 , 文章类型： Article，,卷期：2012年30-6]
- In recent years, the increasing awareness that somatic mutations and other genetic aberrations drive human malignancies has led us within reach of personalized cancer medicine (PCM). The implementation of PCM is based on...
|